Subtype
Malignant Anorectal Neoplasm
CI-CAN-00005864Explore in graph →
452 active trials1 approved drugs6 evidence items
- NCIt
- C215225
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005864Explore in graph →
Clinical trials
1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (174)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00979680 | Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal Carcinoma(GRECCAR1) | completed | Phase 3 | 207 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT03690921 | Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial | completed | Phase 2 | 8 | M.D. Anderson Cancer CenterOTHER |
| 1 |
| Jun 29, 2023 |
| clinicaltrials |
| NCT05907642 | Effects of Dried Plum (Prune) Intake on the Incidence of Low Anterior Resection Syndrome in Patients With Rectal Cancer | completed | N/A | 65 | Samsung Medical CenterOTHER | 1 | Jun 18, 2023 | clinicaltrials |
| NCT02919969 | Pembrolizumab in Metastatic Anal Cancer | completed | Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 12, 2023 | clinicaltrials |
| NCT05893667 | Evaluation of Inflammatory Markers in LARC Patients | completed | — | 245 | Hospital Pedro HispanoOTHER | 0 | Jun 12, 2023 | clinicaltrials |
| NCT05879172 | Electric Tubular Anastomosis in Rectal Cancer | completed | N/A | 400 | LI XIN-XIANGOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05872334 | The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery | completed | N/A | 120 | Samsung Medical CenterOTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT01488045 | Compare Propofol to Fentanyl and Midazolam for Colonoscopy | completed | N/A | 289 | Trinity Health MichiganOTHER | 1 | May 23, 2023 | clinicaltrials |
| NCT04319354 | Evaluation of cfDNA as a Marker of Response in Rectal Cancer | completed | N/A | 50 | Hospital Pedro HispanoOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT02849717 | Pre-Habilitation Exercise Intervention | completed | N/A | 82 | University of RochesterOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT04601727 | Oral & Faecal Microbiota Analysis in Patients With Rectal Cancer Requiring Pre-operative Therapy Before Surgery, & Correlation With Response(MICROBRECT) | completed | — | 26 | University of AberdeenOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05457075 | Immune Checkpoints in Predicting Response to Neoadjuvant Therapy in Rectal Cancer | completed | — | 38 | Istanbul Training and Research HospitalOTHER_GOV | 1 | May 9, 2023 | clinicaltrials |
| NCT00093379 | Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | completed | Phase 2 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05816980 | Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients(Re-RAD-I) | completed | Phase 2 | 16 | Aarhus University HospitalOTHER | 2 | Apr 18, 2023 | clinicaltrials |
| NCT03541304 | High Dose Radiotherapy for the Treatment of Rectal Cancer | completed | — | 48 | Sun Yat-sen UniversityOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT03846726 | Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response | completed | — | 513 | Yuan-hong GaoOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT03392584 | Detection and Inflammatory Characterization of Deep Infection After Surgery for Locally Advanced Rectal Cancer With Microdialysis Catheters | completed | — | 50 | Oslo University HospitalOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT04324567 | Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer(APR-IMM) | completed | — | 55 | Oslo University HospitalOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT05074082 | Perineal Flap Reconstruction Following Surgery for Advanced Pelvic Malignancy | completed | — | 883 | St Vincent's University Hospital, IrelandOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT03427411 | M7824 in Subjects With HPV Associated Malignancies | completed | Phase 2 | 57 | National Cancer Institute (NCI)NIH | 1 | Mar 28, 2023 | clinicaltrials |
| NCT04080414 | Home-based HIIT to Improve CRC Survivorship: Feasibility and Relationship With Novel Surrogate Biomarkers of CRC Recurrence | completed | N/A | 7 | University of UtahOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT03770689 | Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer | completed | Phase 1 / Phase 2 | 19 | EMD Serono Research & Development Institute, Inc.INDUSTRY | 2 | Mar 21, 2023 | clinicaltrials |
| NCT02399813 | A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal | completed | Phase 2 | 36 | Advaxis, Inc.INDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | completed | Phase 2 | 37 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT05040646 | The Development of a Patient Reported Outcomes Measure Committed to the Watch-and-wait Program for Rectal Cancer | completed | — | 80 | Maastricht University Medical CenterOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT03750461 | Stoma Closure and Reinforcement Trial(SCAR) | completed | N/A | 20 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT02890758 | Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | completed | Phase 1 | 14 | Brenda Cooper, MDOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT00579579 | Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer | completed | — | 229 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT03871959 | Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma(CATRIPCA) | completed | Phase 1 | 54 | Centre Leon BerardOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT01444495 | Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer | completed | N/A | 154 | Jagiellonian UniversityOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05723965 | Using Artificial Intelligence to Predict Rectal Cancer Outcomes | completed | — | 720 | Taichung Veterans General HospitalOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT03871790 | Peptide-based Immunization for Colon- and and Pancreas-carcinoma(PICOP-GLOBAL) | completed | — | 50 | CENTOGENE GmbH RostockINDUSTRY | 1 | Feb 10, 2023 | clinicaltrials |
| NCT03043729 | mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | completed | Phase 2 | 119 | AIO-Studien-gGmbHOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05638048 | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients | completed | N/A | 270 | Junyan ZhaoOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT02728804 | S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer | completed | — | 380 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04476082 | Nutrition in Gastrointestinal Tumors(NutriGIT) | completed | — | 66 | University Medicine GreifswaldOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT05682794 | Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort | completed | — | 2,502 | Sun Yat-sen UniversityOTHER | 0 | Jan 12, 2023 | clinicaltrials |
| NCT03297710 | TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery | completed | Phase 1 | 7 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT05667259 | Prognostic Significance of Lymph Node Ratio in Rectal Cancer on Overall Survival | completed | — | 229 | South Valley UniversityOTHER | 1 | Dec 28, 2022 | clinicaltrials |
| NCT05406765 | Enhanced Recovery After Laparoscopic Colorectal Surgery | completed | Phase 4 | 10 | University Hospital of North NorwayOTHER | 1 | Dec 22, 2022 | clinicaltrials |
| NCT04009876 | A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer | completed | Phase 2 | 30 | Fundación de investigación HMOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT05129215 | Development and Validation of The Post-RT LARS Prediction Model (PORTLARS)(PORTLARS) | completed | — | 901 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 30, 2022 | clinicaltrials |
| NCT02810652 | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | completed | N/A | 160 | Massachusetts General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT05622357 | Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer | completed | Phase 2 | 51 | National Cancer Institute, EgyptOTHER | 1 | Nov 18, 2022 | clinicaltrials |
| NCT05610592 | Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status | completed | — | 480 | Sun Yat-sen UniversityOTHER | 1 | Nov 9, 2022 | clinicaltrials |
| NCT05609149 | MRI Features in Neoadjuvant Treatment Decisions for Patients With Rectal Cancer | completed | — | 480 | Sun Yat-sen UniversityOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT05607186 | Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute | completed | — | 59 | Singapore General HospitalOTHER | 0 | Nov 7, 2022 | clinicaltrials |
| NCT04678349 | The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy | completed | N/A | 29 | Universiti Putra MalaysiaOTHER | 1 | Nov 4, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jun 29, 2023source: clinicaltrials